These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7103460)

  • 21. Acyclovir clinical pharmacology. An overview.
    Lietman PS
    Am J Med; 1982 Jul; 73(1A):193-6. PubMed ID: 7048912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
    Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
    Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of fosfomycin in normal and burn patients. Effect of probenecid.
    Potel G; Meignier M; Baron D; Reynaud A; Touze MD; Courtieu AL
    Drugs Exp Clin Res; 1989; 15(4):177-84. PubMed ID: 2776659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologically based pharmacokinetic model for the renal clearance of iodopyracet and the interaction with probenecid in the dog.
    Russel FG; Wouterse AC; Van Ginneken CA
    Biopharm Drug Dispos; 1989; 10(2):137-52. PubMed ID: 2706315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal handling of the monobactam azthreonam in healthy subjects.
    Swabb EA; Sugerman AA; Frantz M; Platt TB; Stern M
    Clin Pharmacol Ther; 1983 May; 33(5):609-14. PubMed ID: 6682362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in rats and rabbits.
    Kim SH; Kim WB; Lee MG
    Antimicrob Agents Chemother; 1999 Jan; 43(1):96-9. PubMed ID: 9869572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3902-7. PubMed ID: 19564368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal clearance of temocillin in volunteers.
    Overbosch D; van Gulpen C; Mattie H
    Drugs; 1985; 29 Suppl 5():128-34. PubMed ID: 4029016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of probenecid on the elimination and protein binding of ceftriaxone.
    Stoeckel K; Trueb V; Dubach UC; McNamara PJ
    Eur J Clin Pharmacol; 1988; 34(2):151-6. PubMed ID: 3383987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No effect of probenecid on the renal and biliary clearances of digoxin in man.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Br J Clin Pharmacol; 1991 Jul; 32(1):63-7. PubMed ID: 1888643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretion.
    Zamboni WC; Houghton PJ; Johnson RK; Hulstein JL; Crom WR; Cheshire PJ; Hanna SK; Richmond LB; Luo X; Stewart CF
    J Pharmacol Exp Ther; 1998 Jan; 284(1):89-94. PubMed ID: 9435165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.
    Vlasses PH; Holbrook AM; Schrogie JJ; Rogers JD; Ferguson RK; Abrams WB
    Antimicrob Agents Chemother; 1980 May; 17(5):847-55. PubMed ID: 7396472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir.
    De Bony F; Tod M; Bidault R; On NT; Posner J; Rolan P
    Antimicrob Agents Chemother; 2002 Feb; 46(2):458-63. PubMed ID: 11796358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of probenecid on enprofylline kinetics in man.
    Borgå O; Larsson R; Lunell E
    Eur J Clin Pharmacol; 1986; 30(2):221-3. PubMed ID: 3709650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of probenecid and the effect of oral probenecid administration on the pharmacokinetics of cefazolin in mares.
    Donecker JM; Sams RA; Ashcraft SM
    Am J Vet Res; 1986 Jan; 47(1):89-95. PubMed ID: 3946913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.
    Verhagen CA; Mattie H; Van Strijen E
    Br J Clin Pharmacol; 1994 Feb; 37(2):193-7. PubMed ID: 8186065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human pharmacokinetics of BL-P1654 compared with ampicillin.
    Clarke JT; Libke RD; Ralph ED; Luthy RP; Kirby WM
    Antimicrob Agents Chemother; 1974 Dec; 6(6):729-33. PubMed ID: 4455125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of probenecid on the pharmacokinetics of ceftizoxime.
    LeBel M; Paone RP; Lewis GP
    J Antimicrob Chemother; 1983 Aug; 12(2):147-55. PubMed ID: 6311785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.